inclisiranevolocumabalirocumabbococizumabtafolecimabPCSK9iatherosclerotic cardiovascular diseaseFamilial hypercholesterolaemia (FH)
… including alirocumab, bococizumab, evolocumab, tafolecimab and inclisiran. Eligible studies reported changes in LDL-C, apolipoprotein B (…